14+ hour, 35+ min ago   (213+ words) C. Prasanna Kumar Reddy has been appointed Assistant General Manager – Analytical Research & Development (AR&D) at MSN Laboratories’ R&D Center, bringing more than 19 years of experience in analytical research, pharmaceutical R&D and laboratory operations. Over the course of his…...

15+ hour, 45+ min ago   (204+ words) Nair spent more than 12 years, progressing from Management Trainee to Head – Sales & Marketing while leading the company’s diabetes portfolio. Vivek Nair has been appointed Senior Vice President – Domestic Business at Macleods Pharmaceuticals, bringing more than 25 years of experience across sales,…...

5+ day, 9+ hour ago   (88+ words) Indian Pharma Post Aptar Pharma and Aceso Therapeutics partner to advance novel cystic fibrosis drug candidate Nanopharm, Aptar Pharma’s specialist inhalation development services business, will lead formulation development and device assessment for ACT-101, supporting Aceso’s clinical development roadmap Chasing Consistency:…...

5+ day, 8+ hour ago   (277+ words) Neurizon Therapeutics has appointed Dr. Chris Bremer as Chief Executive Officer, effective October 1, 2026 while the Australian biotechnology company advances its lead ALS drug candidate NUZ-001. Dr. Bremer will initially serve as CEO and will not join the board of Neurizon…...

5+ day, 14+ hour ago   (341+ words) The expansion will add four new GMP suites, taking the total number of suites at the site from six to 10 The company operates facilities in the UK and US and works with pharmaceutical and biotechnology companies across the lifecycle of…...

1+ week, 2+ hour ago   (374+ words) Under the proposed three-year collaboration, Sanofi will provide Tricog Health with mentorship, market access support and potential financial investment Prateek Golecha, Chief Growth Officer, Tricog Health (L) with Deepak Arora, Managing Director, Sanofi India (R) Sanofi Healthcare India Pvt. Ltd. has signed…...

1+ week, 14+ hour ago   (289+ words) Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (Fosun Pharma) has announced an H-share repurchase plan of up to HK$1 billion, with the repurchased shares to be either cancelled or held as treasury shares. The company said the programme has come into…...

1+ week, 1+ day ago   (444+ words) The acquisition further positions Cyrix Healthcare to expand its presence across the MedTech value chain, while building scale in India and creating a platform for longer-term expansion across the Middle East and Africa Cyrix Healthcare, a portfolio company of Somerset…...

1+ week, 1+ day ago   (209+ words) The company said its growing experimental throughput requires digital infrastructure capable of rapidly converting large volumes of discovery data into actionable insights. Brandon Clavette, VP Research & Development at Evolved Therapeutics, said the company chose ENPICOM because the platform is purpose-built…...

1+ week, 1+ day ago   (179+ words) Jubilant Biosys Limited has expanded Jay Sheth’s leadership mandate with his appointment as Head of CDMO, North America, alongside his existing role as AVP, Business Development & Global Head of Venture Capital Relations. He will continue to oversee Jubilant Biosys’ global…...